![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEirLBTWEoOtAumyNpcbvNGQHFn87AE4nzxZT3mT7L0PKJSDS-L2LkwJo5JgL1wqa_-WEeNMADQ3s2CirlOCB0_j5pzkiFz_ukoOou7t-TrDc6QTY6hs2xvq2WWDvm0Q93G0jGe7GoHpRTer/s1600/rsz_graylogo_copy_2.jpg)
Esmolol (Brevibloc) is an ultrashort-acting β1-blocker with a half-life of 9 minutes, rapidly converting to inactive metabolites by blood esterases. Full recovery from β-blockade occurs within 30 minutes in patients with a normal cardiovascular system.
No comments :
Post a Comment